Share

EORTC Genito-Urinary Cancer Group Autumn Meeting 2024

EORTC HQ, Brussels, Belgium

The EORTC Genito-Urinary Cancer Group Autumn meeting will be held as a hybrid meeting in Brussels, Belgium on 27 November 2024. It is only open to individual or site staff members of the group.

Registrations for the meeting are open and the link was sent by email. In case you are an individual or site staff member of the EORTC Genito-Urinary Cancer Group, and you have not received the registration link, please contact events@eortc.org.

Venue:

EORTC HQ, Avenue E. Mounier 83/11, Tagnon meeting room, 5th floor

MEETING AGENDA

09:30 Opening & Chairman’s Report
Remaining positions within Steering
Committee
Dr Loriot
HQ
09:45 GUCG Y-ECIs Dr Grisay,
Dr Van Damme
09:50 IMMUcan update: the possibility of EORTC network to propose projects to analyse data/samples collected in IMMUcan. HQ
10:00 Summary of the new GUCG proposals

  • Update on Proposal: nMIBC with radiotherapy by Dr Achard, Prof Dirix, Prof Sargos Prof Roupret
  • Update on Proposal: ESCALATE RT in PC by Prof Zilli, Prof Tombal, Prof Gillessen and Prof Ost
  • Update on Proposal: STARBURST neoadjuvant precision medicine study in MIBC by Dr Loriot and Prof Masson-Lecomte
  • Update on proposal 2433 PEANUT proposal by Dr Seisen and Dr Thibault
  • Update on 2361 RENALUT 177Lutetium-PSMA treatment in patients with metastatic clear cell RCC by Prof Goffin, Prof Tombal, Dr Albiges and Dr Seront
  •  2405 EVOLVE presentation by Prof Powles and Van der Heijden
  • DETOX trial – De-escalation and optimisation of Radiotherapy Volume to Improve Quality of Life and Reduce Toxicity in frail/elderly population. A platform trial
Lead Investigators
As listed with proposal title
12:00 Lunch break
13:15  EORTC 2238 DE-ESCALATE  Prof Tombal
Prof Gillessen
13:30  1414-ROG-GUCG (DEGARELIX)  Dr Zilli/HQ
13:45  1407-GUCG (TIGER)  Dr Thomas Powles or Prof Gillessen / HQ
13:50  1333-GUCG (PEACE III)  HQ
14:00  1532-GUCG (ODM-201)  HQ
14:05  GU-related QoL modules and collaboration possibilities  Renée Bultijnck
14:20  Rare tumours and ADC group  Dr Pablo Maroto
14:30  Slot for Nuclear Medicine  TBC
14:40  New concepts: 2 stage consent  HQ
15:00  Q&A + closure of the meeting  Dr Loriot/HQ
16:00  Meeting end

Next events

  • EORTC Imaging Group Spring Meeting 2025

    Brussels, BE

  • 6th EORTC Quality of Life in Cancer Clinical Trials Conference

    Barcelona, Spain

  • EORTC Lung Cancer Group Spring Meeting 2025

    genoa, Italy

  • EORTC Pathobiology Group Spring Meeting 2025

    Virtual Event

  • Clinical Trial Statistics for Non-Statisticians 25

    Brussels, BE